Manufacturers Life Insurance Company, The Compass Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $114 Billion
- Q3 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 33,161 shares of CMPX stock, worth $161,825. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,161
Previous 35,553
6.73%
Holding current value
$161,825
Previous $92,000
34.78%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CMPX
# of Institutions
128Shares Held
143MCall Options Held
1.02MPut Options Held
0-
Tang Capital Management LLC San Diego, CA16.8MShares$82 Million2.87% of portfolio
-
Orbimed Advisors LLC San Diego, CA15.2MShares$74.3 Million1.95% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.1MShares$68.8 Million1.59% of portfolio
-
Blackstone Inc New York, NY9.84MShares$48 Million0.17% of portfolio
-
Vivo Capital, LLC Palo Alto, CA9.55MShares$46.6 Million5.69% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $494M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...